<DOC>
	<DOC>NCT02680340</DOC>
	<brief_summary>The primary purpose of this study is to demonstrate the POLARSTEM™ Ti/HA cumulative femoral stem revision rate at 10 years. The secondary purpose of this study is to provide 10 years of safety and effectiveness data of POLARSTEM™ Ti/HA in terms of radiographic and clinical performance</brief_summary>
	<brief_title>POLARSTEM Retrospective Multicenter Study</brief_title>
	<detailed_description>This is a multicenter retrospective longterm clinical outcome study conducted in up to 6 hospitals in France. 502 subjects who have undergone THA with POLARSTEM™ from 2002 to 2005 will be enrolled in this study and clinical and radiographically followed up for at least 10 years. Subjects who have not reached the 10-year post surgery timepoint will be invited to a 10-year post-operative follow-up visit to obtain the clinical and radiographic outcome measures.</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>1. Subject required and received primary total hip arthroplasty between 2002 and 2005. 2. Subject received the POLARSTEM™ Ti/HA unilateral or bilateral, due to severe hip joint damage resulting from arthrosis, degenerative disease, traumatic events, inflammatory or rheumatoid processes. 3. Subject received the noncemented POLARSYSTEM (POLARSTEM™ Ti/HA in combination with POLARCUP™). 4. Subject was aged between 18 and 75 at time of surgery. 5. Signed Informed Consent (ICF). 1. Subject received the cemented POLARSTEM™. 2. Previously failed endoprosthesis and/or THR components in relevant hip. 3. Medical or mental health conditions which could impair the stubject's ability or willingness to comply with the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Total Hip Arthroplasty THA</keyword>
</DOC>